OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review

September 2018 | 52 pages | ID: O965DCBB815EN
GlobalData

Abstracts

OPKO Health Inc (OPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers its diagonostics and therapeutics that are used in the treatment of chronic kidney disease, obesity, asthma, chronic obstructive pulmonary disease (COPD), cancer and chemotherapy-induced nausea and vomiting, among others. It also offers neutraceuticals and veterinary products.The company also offers contract research services to other pharmaceutical companies. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.

OPKO Health Inc Key Recent Developments

Sep 07,2018: SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes
Aug 07,2018: Opko Health announces second quarter 2018 financial results
May 08,2018: OPKO Health Announces First Quarter 2018 Financial Results
May 01,2018: OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
Mar 01,2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

OPKO Health Inc - Key Facts
OPKO Health Inc - Key Employees
OPKO Health Inc - Key Employee Biographies
OPKO Health Inc - Major Products and Services
OPKO Health Inc - History
OPKO Health Inc - Company Statement
OPKO Health Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
OPKO Health Inc - Business Description
Business Segment: Diagnostics
Overview
Performance
Key Stats
Business Segment: Pharmaceutical
Overview
Performance
Geographical Segment: Chile
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: Israel
Performance
Geographical Segment: Mexico
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: Spain
Performance
Geographical Segment: the US
Performance
R&D Overview
OPKO Health Inc - Corporate Strategy
OPKO Health Inc - SWOT Analysis
SWOT Analysis - Overview
OPKO Health Inc - Strengths
OPKO Health Inc - Weaknesses
OPKO Health Inc - Opportunities
OPKO Health Inc - Threats
OPKO Health Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
OPKO Health Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 07, 2018: SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes
May 01, 2018: OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
Mar 01, 2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results
Nov 08, 2017: OPKO Health Reports 2017 Third Quarter Highlights and Financial Results
Sep 19, 2017: OPKO’s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care
Sep 12, 2017: OPKO’s GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings
Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories
Aug 21, 2017: Update: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories
Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories
Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

OPKO Health Inc, Key Facts
OPKO Health Inc, Key Employees
OPKO Health Inc, Key Employee Biographies
OPKO Health Inc, Major Products and Services
OPKO Health Inc, History
OPKO Health Inc, Other Locations
OPKO Health Inc, Subsidiaries
OPKO Health Inc, Key Competitors
OPKO Health Inc, Ratios based on current share price
OPKO Health Inc, Annual Ratios
OPKO Health Inc, Annual Ratios (Cont.1)
OPKO Health Inc, Interim Ratios
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
OPKO Health Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

OPKO Health Inc, Performance Chart (2013 - 2017)
OPKO Health Inc, Ratio Charts
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
OPKO Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Quest Diagnostics Inc
Laboratory Corp of America Holdings
Siemens Healthcare GmbH
Novartis AG